{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:19:46Z","timestamp":1785849586125,"version":"3.56.0"},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-0510","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T17:09:04Z","timestamp":1517245744000},"page":"1168-1178","source":"Crossref","is-referenced-by-count":38,"title":["Long-Term Clinical Outcomes Survey of Bone Marrow-Derived Cell Therapy in Critical Limb Ischemia in Japan"],"prefix":"10.1253","volume":"82","author":[{"given":"Kazuhisa","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yanishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Hayashida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Murotani","sequence":"additional","affiliation":[{"name":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadami","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoaki","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TACT Follow-up Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). <i>J Vasc Surg<\/i> 2007; 45(Suppl S): S5\u2013S67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Luders F, et al. Peripheral arterial disease and critical limb ischaemia: Still poor outcomes and lack of guideline adherence. <i>Eur Heart J<\/i> 2015; 36: 932\u2013938.","DOI":"10.1093\/eurheartj\/ehv006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. <i>Lancet<\/i> 1996; 348: 370\u2013374.","DOI":"10.1016\/S0140-6736(96)03361-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. <i>J Clin Invest<\/i> 2000; 105: 1527\u20131536.","DOI":"10.1172\/JCI8296"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. <i>Circulation<\/i> 2001; 103: 897\u2013903.","DOI":"10.1161\/01.CIR.103.6.897"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. <i>Lancet<\/i> 2002; 360: 427\u2013435.","DOI":"10.1016\/S0140-6736(02)09670-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. <i>Am Heart J<\/i> 2008; 156: 1010\u20131018.","DOI":"10.1016\/j.ahj.2008.06.025"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Idei N, Soga J, Hata T, Fujii Y, Fujimura N, Mikami S, et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: A comparison of atherosclerotic peripheral arterial disease and Buerger disease. <i>Circ Cardiovasc Interv<\/i> 2011; 4: 15\u201325.","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Benoit E, O\u2019Donnell TF, Patel AN. Safety and efficacy of autologous cell therapy in critical limb ischemia: A systematic review. <i>Cell Transplant<\/i> 2013; 22: 545\u2013562.","DOI":"10.3727\/096368912X636777"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. <i>Atherosclerosis<\/i> 2010; 209: 10\u201317.","DOI":"10.1016\/j.atherosclerosis.2009.08.033"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study. <i>J Am Soc Nephrol<\/i> 2002; 13: 1918\u20131927.","DOI":"10.1097\/01.ASN.0000019641.41496.1E"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cavender MA, Steg PG, Smith SC Jr, Eagle K, Ohman EM, Goto S, et al. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: Outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. <i>Circulation<\/i> 2015; 132: 923\u2013931.","DOI":"10.1161\/CIRCULATIONAHA.114.014796"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Miyahara T, Suhara M, Nemoto Y, Shirasu T, Haga M, Mochizuki Y, et al. Long-term results of treatment for critical limb ischemia. <i>Ann Vasc Dis<\/i> 2015; 8: 192\u2013197.","DOI":"10.3400\/avd.oa.15-00074"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ohta T, Ishioashi H, Hosaka M, Sugimoto I. Clinical and social consequences of Buerger disease. <i>J Vasc Surg<\/i> 2004; 39: 176\u2013180.","DOI":"10.1016\/j.jvs.2003.08.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Deguchi J, Shigematsu K, Ota S, Kimura H, Fukayama M, Miyata T. Surgical result of critical limb ischemia due to tibial arterial occlusion in patients with systemic scleroderma. <i>J Vasc Surg<\/i> 2009; 49: 918\u2013923.","DOI":"10.1016\/j.jvs.2008.10.066"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Al-Omran M, Tu JV, Johnston KW, Mamdani MM, Kucey DS. Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: A population-based study. <i>J Vasc Surg<\/i> 2003; 38: 279\u2013288.","DOI":"10.1016\/S0741-5214(03)00274-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Eskelinen E, Eskelinen A, Alb\u00e4ck A, Lep\u00e4ntalo M. Major amputation incidence decreases both in non-diabetic and in diabetic patients in Helsinki. <i>Scand J Surg<\/i> 2006; 95: 185\u2013189.","DOI":"10.1177\/145749690609500311"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nowygrod R, Egorova N, Greco G, Anderson P, Gelijns A, Moskowitz A, et al. Trends, complications, and mortality in peripheral vascular surgery. <i>J Vasc Surg<\/i> 2006; 43: 205\u2013216.","DOI":"10.1016\/j.jvs.2005.11.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. <i>J Vasc Surg<\/i> 2009; 50: 54\u201360.","DOI":"10.1016\/j.jvs.2009.01.035"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Benoit E, O\u2019Donnell TF Jr, Kitsios GD, Iafrati MD. Improved amputation free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. <i>J Vasc Surg<\/i> 2012; 55: 781\u2013789.","DOI":"10.1016\/j.jvs.2011.10.089"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Iida O, Nakamura M, Yamauchi Y, Fukunaga M, Yokoi Y, Yokoi H, et al. 3-Year outcomes of the OLIVE Registry, a prospective multicenter study of patients with critical limb ischemia: A prospective, multi-center, three-year follow-up study on endovascular treatment for infra-inguinal vessel in patients with critical limb ischemia. <i>JACC Cardiovasc Interv<\/i> 2015; 8: 1493\u20131502.","DOI":"10.1016\/j.jcin.2015.07.005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Teraa M, Sprengers RW, van der Graaf Y, Peters CE, Moll FL, Verhaar MC. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: A meta-analysis of randomized controlled clinical trials. <i>Ann Surg<\/i> 2013; 258: 922\u2013929.","DOI":"10.1097\/SLA.0b013e3182854cf1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Peeters Weem SM, Teraa M, de Borst GJ, Verhaar MC, Moll FL. Bone marrow derived cell therapy in critical limb ischemia: A meta-analysis of randomized placebo controlled trials. <i>Eur J Vasc Endovasc Surg<\/i> 2015; 50: 775\u2013783.","DOI":"10.1016\/j.ejvs.2015.08.018"},{"key":"24","unstructured":"24. Molavi B, Zafarghandi MR, Aminizadeh E, Hosseini SE, Mirzayi H, Arab L, et al. Safety and efficacy of repeated bone marrow mononuclear cell therapy in patients with critical limb ischemia in a pilot randomized controlled trial. <i>Arch Iran Med<\/i> 2016; 19: 388\u2013396."}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/4\/82_CJ-17-0510\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T19:08:18Z","timestamp":1570648098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/4\/82_CJ-17-0510\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0510","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}